Mar 08, 2017 01:17 PM IST | Source: Moneycontrol.com

Unichem Laboratories receives ANDA approval for Rizatriptan Benzoate ODT & Rizatriptan Benzoate tablets USP

Unichem Laboratories has received ANDA approval from the United States Food and Drug Administration (USFDA) for Rizatriptan Benzoate ODT 5mg & 10mg and Rizatriptan Benzoate Tablets USP, 5mg & 10mg which are therapeutically equivalent to Maxalt – MLT Tablets 5mg & 10mg and Maxalt Tablets 5mg 10mg of Merck & Company, Inc.

Unichem Laboratories receives ANDA approval for Rizatriptan Benzoate ODT & Rizatriptan Benzoate tablets USP

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith the press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (U.S. FDA) for Rizatriptan Benzoate ODT 5mg & 10mg and Rizatriptan Benzoate Tablets USP, 5mg & 10mg which are therapeutically equivalent to Maxalt

Sections
Follow us on
Available On